MX343327B - Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa. - Google Patents
Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.Info
- Publication number
- MX343327B MX343327B MX2013009570A MX2013009570A MX343327B MX 343327 B MX343327 B MX 343327B MX 2013009570 A MX2013009570 A MX 2013009570A MX 2013009570 A MX2013009570 A MX 2013009570A MX 343327 B MX343327 B MX 343327B
- Authority
- MX
- Mexico
- Prior art keywords
- tnfa
- assays
- present
- autoantibodies
- detecting autoantibodies
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161444097P | 2011-02-17 | 2011-02-17 | |
US201161484594P | 2011-05-10 | 2011-05-10 | |
US201161496501P | 2011-06-13 | 2011-06-13 | |
PCT/US2012/025437 WO2012154253A1 (en) | 2011-02-17 | 2012-02-16 | ASSAYS FOR DETECTING AUTOANTIBODIES TO ANTI-TNFα DRUGS |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013009570A MX2013009570A (es) | 2013-09-06 |
MX343327B true MX343327B (es) | 2016-11-01 |
Family
ID=45809635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013009570A MX343327B (es) | 2011-02-17 | 2012-02-16 | Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa. |
Country Status (17)
Country | Link |
---|---|
US (1) | US20140045276A1 (he) |
EP (1) | EP2676137B1 (he) |
JP (1) | JP6063398B2 (he) |
KR (1) | KR20140008397A (he) |
CN (1) | CN103502815B (he) |
AU (1) | AU2012254150B2 (he) |
BR (1) | BR112013020981A2 (he) |
CA (1) | CA2827609A1 (he) |
DK (1) | DK2676137T3 (he) |
ES (1) | ES2530175T3 (he) |
HK (1) | HK1191688A1 (he) |
IL (1) | IL227853A (he) |
MX (1) | MX343327B (he) |
RU (1) | RU2013142278A (he) |
SG (1) | SG192770A1 (he) |
WO (1) | WO2012154253A1 (he) |
ZA (1) | ZA201306950B (he) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
CN104634955B (zh) | 2009-10-26 | 2016-09-14 | 雀巢产品技术援助有限公司 | 检测抗-tnf药物和自身抗体的试验 |
EP2630495B1 (en) | 2010-10-18 | 2017-02-08 | Nestec S.A. | Methods for determining anti-drug antibody isotypes |
KR20140047628A (ko) | 2011-07-06 | 2014-04-22 | 네스텍 소시에테아노님 | Tnf알파로의 생물학적 치료요법에 대한 중화 자가항체의 검출을 위한 검정 |
CN104718453B (zh) * | 2012-10-03 | 2017-03-08 | Gyros专利公司 | 酸性条件下分析物测定用方法和试剂盒 |
AU2013326070A1 (en) | 2012-10-05 | 2015-04-23 | Société des Produits Nestlé S.A. | Methods for predicting and monitoring mucosal healing |
BR112015012482A2 (pt) * | 2012-11-30 | 2017-07-11 | Nestec Sa | ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicos |
EP2954329A1 (en) | 2013-02-05 | 2015-12-16 | Nestec S.A. | Methods of selecting combination therapy for colorectal cancer patients |
BR112015024752A2 (pt) | 2013-03-27 | 2017-07-18 | Cedars Sinai Medical Center | mitigação e reversão da fibrose e inflamação através da inibição da função de tl1a e vias de sinalização relacionadas |
WO2015010108A1 (en) | 2013-07-19 | 2015-01-22 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
EP3077818B1 (en) | 2013-12-03 | 2020-02-05 | Prometheus Biosciences, Inc. | Methods for predicting post-operative recurrence of crohn's disease |
WO2015110989A1 (en) | 2014-01-23 | 2015-07-30 | Nestec S.A. | Biomarker panel for assessment of mucosal healing |
SG10201906750XA (en) | 2014-02-11 | 2019-09-27 | Genzyme Corp | Assays for detecting the presence or amount of an anti-drug antibody |
WO2015154052A1 (en) | 2014-04-04 | 2015-10-08 | Mayo Foundation For Medical Education And Research | Isotyping immunoglobulins using accurate molecular mass |
CN104034896A (zh) * | 2014-06-19 | 2014-09-10 | 华北制药集团新药研究开发有限责任公司 | 一种双抗体夹心elisa检测方法 |
US10690676B2 (en) | 2014-07-29 | 2020-06-23 | Mayo Roundation for Medical Education and Research | Quantifying monoclonal antibody therapeutics by LC-MS/MS |
EP3210016A1 (en) * | 2014-10-20 | 2017-08-30 | Nestec S.A. | Methods for prediction of anti-tnf alpha drug levels and autoantibody formation |
MX2017005156A (es) * | 2014-11-05 | 2017-08-08 | Hoffmann La Roche | Metodo para determinacion de anticuerpos de anti-farmaco contra anticuerpo de farmaco humano o humanizado de funcion efectora suprimida. |
EP3227683B1 (en) | 2014-12-05 | 2019-04-24 | Nestec S.A. | Indirect homogeneous mobility shift assays for the detection of biologics in patient samples |
US11085931B2 (en) | 2015-01-09 | 2021-08-10 | W. Health L.P. | Universal assay for determining the quantity of TNFα inhibitory drugs and their corresponding anti-drug-antibodies |
WO2016135707A1 (en) | 2015-02-27 | 2016-09-01 | Nestec S.A. | Diagnosis of major depressive disorder, mild cognitive impairment, and alzheimer's disease and other neurologic and psychiatric disorders |
AU2016326757B2 (en) | 2015-09-24 | 2022-09-01 | Mayo Foundation For Medical Education And Research | Identification of immunoglobulin free light chains by mass spectrometry |
EP3165922B1 (en) * | 2015-11-06 | 2020-06-17 | Promise Proteomics | A method for quantifying therapeutic antibodies |
US11186872B2 (en) | 2016-03-17 | 2021-11-30 | Cedars-Sinai Medical Center | Methods of diagnosing inflammatory bowel disease through RNASET2 |
EP3482199A1 (en) | 2016-07-08 | 2019-05-15 | Atonomics A/S | A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples |
JP7060510B2 (ja) * | 2016-09-06 | 2022-04-26 | 富士レビオ株式会社 | 腫瘍マーカーの測定方法及び測定試薬 |
WO2018049001A1 (en) | 2016-09-07 | 2018-03-15 | Mayo Foundation For Medical Education And Research | Identification and monitoring of cleaved immunoglobulins by molecular mass |
EP3681528A4 (en) | 2017-09-13 | 2021-07-21 | Mayo Foundation for Medical Education and Research | IDENTIFICATION AND MONITORING OF THE APOPTOSIS INHIBITOR OF MACROPHAGES |
KR20210041009A (ko) * | 2018-08-03 | 2021-04-14 | 브리스톨-마이어스 스큅 컴퍼니 | 항-약물 항체를 검출하는 방법 |
JP2020115139A (ja) * | 2020-03-11 | 2020-07-30 | 国立大学法人千葉大学 | 血管炎の検査方法 |
CN112362649B (zh) * | 2020-11-09 | 2024-07-12 | 长春金赛药业有限责任公司 | 一种rhGH中和抗体的检测方法 |
KR102562006B1 (ko) | 2020-11-09 | 2023-08-02 | 바디텍메드(주) | 항tnf-알파 약물 모니터링을 위한 신속 검출 키트 |
KR102568430B1 (ko) * | 2020-11-16 | 2023-08-24 | 바디텍메드(주) | 항 약물 항체의 신속 검출 방법 |
CN114236139A (zh) * | 2021-12-30 | 2022-03-25 | 苏州和锐生物科技有限公司 | 一种TNF-α生物制剂的抗体检测试剂盒、制备方法 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4459359A (en) * | 1981-11-19 | 1984-07-10 | New York Blood Center, Inc. | Sensitive immunoassays of antigens or antibodies sequestered within immune complexes |
FR2590674B1 (fr) * | 1985-11-25 | 1989-03-03 | Inst Nat Sante Rech Med | Nouveaux reactifs de diagnostic |
DE3631229A1 (de) | 1986-09-13 | 1988-03-24 | Basf Ag | Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung |
US5094740A (en) * | 1990-02-16 | 1992-03-10 | Glycomed, Inc. | Two-dimensional electrophoretic separation of carbohydrates |
GB9028123D0 (en) * | 1990-12-28 | 1991-02-13 | Erba Carlo Spa | Monoclonal antibodies against human tumor necrosis factor alpha |
US6074835A (en) | 1996-04-12 | 2000-06-13 | Regents Of The Univ. Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1 |
US6033864A (en) | 1996-04-12 | 2000-03-07 | The Regents Of The University Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens |
US6406862B1 (en) | 1998-10-06 | 2002-06-18 | The United States Of America As Represented By The Secretary Of The Army | Dip-stick assay for C-reactive protein |
EP1159003B1 (en) * | 1999-03-02 | 2010-11-17 | Centocor, Inc. | Anti-tnf alpha antibodies in therapy of steroid resistant asthma |
US6309643B1 (en) | 1999-04-30 | 2001-10-30 | The Regents Of The University Of California | IBD-associated microbial antigens and methods of using same |
FR2802536B1 (fr) | 1999-11-23 | 2003-06-13 | Chru Lille | Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections |
FR2806739B1 (fr) | 2000-03-27 | 2005-02-18 | Fond Jean Dausset Ceph | Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation |
US6838250B2 (en) | 2000-03-31 | 2005-01-04 | Ortho-Clinical Diagnostics, Inc. | Immunoassay for C-reactive protein |
US7138237B1 (en) | 2000-05-19 | 2006-11-21 | Cedars-Sinai Medical Center | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
EP1330525B1 (en) | 2000-10-30 | 2012-12-05 | The Regents Of The University Of Michigan | Nod2 nucleic acids and proteins |
ES2486340T3 (es) | 2000-10-30 | 2014-08-18 | The Regents Of The University Of Michigan | Ácidos nucleicos y proteínas Nod2 |
AU2002902A (en) | 2000-11-14 | 2002-05-27 | Techlab Inc | Method for differentiating irritable bowel syndrome from inflammatory bowel disease (ibd) and for monitoring persons with ibd using total endogenous lactoferrinas a marker |
ES2405405T3 (es) | 2001-12-17 | 2013-05-31 | Corixa Corporation | Composiciones y procedimientos para la terapia y el diagnóstico de enfermedad inflamatoria del intestino |
US20040053263A1 (en) | 2002-08-30 | 2004-03-18 | Abreu Maria T. | Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
AU2003284187B2 (en) | 2002-10-25 | 2009-10-01 | Techlab, Inc. | Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel |
US7662569B2 (en) | 2003-04-11 | 2010-02-16 | Cedars-Sinai Medical Center | Methods of assessing Crohn's disease patient phenotype by I2 serologic response |
EP1687447A4 (en) | 2003-11-03 | 2008-04-02 | Univ Duke | METHODS FOR IDENTIFYING INDIVIDUALS WITH PERIOPERATIVE RISK OF BLEEDING, RENAL DYSFUNCTION OR ICTUS |
WO2006004958A2 (en) * | 2004-06-30 | 2006-01-12 | Centocor, Inc. | Detection or measurement of antibodies to antigenic proteins in biological tissues or samples |
WO2006012472A1 (en) | 2004-07-21 | 2006-02-02 | Qualyst, Inc. | Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation |
JP2007147367A (ja) * | 2005-11-25 | 2007-06-14 | Sekisui Chem Co Ltd | サイトカイン産生能の測定方法 |
WO2008059515A2 (en) | 2006-08-01 | 2008-05-22 | Divyank Turakhia | A system and method of generating related words and word concepts |
CN104198705B (zh) | 2006-09-21 | 2017-06-09 | 雀巢产品技术援助有限公司 | 检测稀有循环细胞内多种信号转导分子的基于抗体的阵列 |
BRPI0813583A2 (pt) | 2007-07-13 | 2014-12-30 | Prometheus Lab Inc | Métodos para selecionar um medicamento anticâncer, para identificar a resposta de um tumor pulmonar, e para prognosticar a resposta de um paciente, e, arranjo |
US20090035216A1 (en) * | 2007-08-03 | 2009-02-05 | Biomonitor Aps | Method for determining in vivo biopharmaceutical concentration or bioavailability |
WO2009022001A1 (en) * | 2007-08-16 | 2009-02-19 | Novartis Ag | Improvement of drug tolerance in immunogenicity testing |
CA2712021A1 (en) * | 2008-01-15 | 2009-07-23 | Stichting Sanquin Bloedvoorziening | Methods and kits for detecting antibodies against therapeutic antibodies |
WO2009108637A1 (en) | 2008-02-25 | 2009-09-03 | Prometheus Laboratories, Inc. | Drug selection for breast cancer therapy using antibody-based arrays |
WO2010042031A1 (en) * | 2008-10-07 | 2010-04-15 | Gyros Patent Ab | Semi-sequential assay for detection of an analyte in a sample |
CA2761777A1 (en) | 2009-05-14 | 2010-11-18 | Prometheus Laboratories Inc. | Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy |
ES2627909T3 (es) | 2009-07-15 | 2017-08-01 | Diatech Holdings, Inc. | Selección de fármacos para el tratamiento del cáncer gástrico usando matrices basadas en anticuercuerpos |
US8408369B2 (en) | 2009-09-08 | 2013-04-02 | GM Global Technology Operations LLC | Bimetallic brake rotor |
JP5819307B2 (ja) | 2009-10-20 | 2015-11-24 | ネステク ソシエテ アノニム | 発癌性融合タンパク質を検出するための近接媒介性アッセイ |
CN104634955B (zh) * | 2009-10-26 | 2016-09-14 | 雀巢产品技术援助有限公司 | 检测抗-tnf药物和自身抗体的试验 |
-
2012
- 2012-02-16 WO PCT/US2012/025437 patent/WO2012154253A1/en active Application Filing
- 2012-02-16 RU RU2013142278/15A patent/RU2013142278A/ru not_active Application Discontinuation
- 2012-02-16 MX MX2013009570A patent/MX343327B/es active IP Right Grant
- 2012-02-16 CA CA2827609A patent/CA2827609A1/en not_active Abandoned
- 2012-02-16 CN CN201280018741.1A patent/CN103502815B/zh not_active Expired - Fee Related
- 2012-02-16 ES ES12707193.4T patent/ES2530175T3/es active Active
- 2012-02-16 DK DK12707193.4T patent/DK2676137T3/en active
- 2012-02-16 KR KR1020137024583A patent/KR20140008397A/ko not_active Application Discontinuation
- 2012-02-16 JP JP2013554602A patent/JP6063398B2/ja not_active Expired - Fee Related
- 2012-02-16 AU AU2012254150A patent/AU2012254150B2/en not_active Ceased
- 2012-02-16 EP EP12707193.4A patent/EP2676137B1/en active Active
- 2012-02-16 BR BR112013020981A patent/BR112013020981A2/pt not_active Application Discontinuation
- 2012-02-16 SG SG2013061692A patent/SG192770A1/en unknown
-
2013
- 2013-08-07 US US13/961,841 patent/US20140045276A1/en not_active Abandoned
- 2013-09-03 IL IL227853A patent/IL227853A/he active IP Right Grant
- 2013-09-16 ZA ZA2013/06950A patent/ZA201306950B/en unknown
-
2014
- 2014-05-12 HK HK14104474.1A patent/HK1191688A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BR112013020981A2 (pt) | 2016-10-11 |
RU2013142278A (ru) | 2015-03-27 |
KR20140008397A (ko) | 2014-01-21 |
US20140045276A1 (en) | 2014-02-13 |
IL227853A0 (he) | 2013-09-30 |
WO2012154253A1 (en) | 2012-11-15 |
SG192770A1 (en) | 2013-09-30 |
CN103502815A (zh) | 2014-01-08 |
ZA201306950B (en) | 2015-04-29 |
MX2013009570A (es) | 2013-09-06 |
IL227853A (he) | 2017-07-31 |
HK1191688A1 (en) | 2014-08-01 |
EP2676137A1 (en) | 2013-12-25 |
CN103502815B (zh) | 2015-09-23 |
EP2676137B1 (en) | 2014-12-31 |
CA2827609A1 (en) | 2012-11-15 |
JP6063398B2 (ja) | 2017-01-18 |
AU2012254150B2 (en) | 2015-08-13 |
AU2012254150A1 (en) | 2013-05-02 |
ES2530175T3 (es) | 2015-02-26 |
JP2014508930A (ja) | 2014-04-10 |
NZ614170A (en) | 2015-04-24 |
DK2676137T3 (en) | 2015-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX343327B (es) | Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa. | |
MX2012004877A (es) | Analisis para la deteccion de farmacos anti-tnf y autoanticuerpos. | |
BR112013010952A2 (pt) | sistemas de rmn e métodos para a detecção rápida de analisados | |
MX358517B (es) | Métodos para determinar eficacia de fármacos usando proteínas asociadas a cereblon. | |
BRPI1007321A2 (pt) | métodos para medir e/ou quantificar a presença e/ou quantidade de her-3 ou her-3 em um complexo em uma amostra de um paciente, e para determinar se um indivíduo com um câncer é provável de responder ao tratamento com uma terapia alvejada, e, anticorpo. | |
NZ627443A (en) | Biological markers for identifying patients for treatment with vegf antagonists | |
MX361944B (es) | Metodos para detectar firmas de enfermedad o condiciones en fluidos corporales. | |
MX345230B (es) | Metodos para diagnosticar patogenos de enfermedad infecciosa y su sensibilidad a farmacos. | |
MX343324B (es) | Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha. | |
MX349561B (es) | Método para detectar nucleosomas que contienen variantes de histonas. | |
WO2013030578A3 (en) | Method for detecting nucleosomes | |
IL222251A0 (en) | Methods, system and apparatus for the detection, diagnosis and treatment of biological rhythm disorders | |
MX2012010418A (es) | Inhibidores syk de imidazopiridinas. | |
MX364410B (es) | Metodo para detectar nucleosomas que contienen nucleotidos. | |
NZ609493A (en) | Diagnosis and treatments relating to th2 inhibition | |
BR112013010015A2 (pt) | aparelho e método para detecção não invasiva de doenças que afetam as propriedades estruturais em tecidos biológicos | |
EA201291396A1 (ru) | Способ детекции молекулярных взаимодействий | |
MX2015006852A (es) | Ensayos para detectar autoanticuerpos neutralizantes para terapia biologica. | |
MX2013000674A (es) | Metodo para identificar a un paciente con incrementada probabilidad de responder a una terapia anticancer. | |
MX358474B (es) | Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson. | |
GB201206977D0 (en) | An enzyme detection device | |
EP2573192A4 (en) | METHOD AND KIT FOR DIAGNOSING DISEASE ASSOCIATED WITH AIM | |
WO2015049390A3 (en) | Kidney disease biomarker | |
MX2021009528A (es) | Prueba de diagnostico basada en fragmento de rgma. | |
WO2014052685A3 (en) | Devices and methods for single cell analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |